• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Extended pancreatoduodenectomy with portal vein and inferior vena cava resection and reconstruction combined with sorafenib for hepatoid carcinoma of the pancreas: a strategy of superextended surgery combined with targeted therapy.

作者信息

Wei Deling, Xu Banghao, Zhu Hai, Wang Jilong, Jin Zongrui, Chen Weitao, Zhang Jianyong, Lan Zhujing, Huang Keyu, Zhang Ling, Lu Tingting, Fang Ni, Guo Ya, Peng Tao, Peng Minhao, Wen Zhang

机构信息

Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Department of Radiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.

出版信息

Hepatobiliary Surg Nutr. 2023 Aug 1;12(4):637-640. doi: 10.21037/hbsn-23-74. Epub 2023 Jul 14.

DOI:10.21037/hbsn-23-74
PMID:37601006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10432294/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c21/10432294/a92102fb3ddd/hbsn-12-04-637-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c21/10432294/8f807036dd00/hbsn-12-04-637-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c21/10432294/a92102fb3ddd/hbsn-12-04-637-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c21/10432294/8f807036dd00/hbsn-12-04-637-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c21/10432294/a92102fb3ddd/hbsn-12-04-637-f2.jpg

相似文献

1
Extended pancreatoduodenectomy with portal vein and inferior vena cava resection and reconstruction combined with sorafenib for hepatoid carcinoma of the pancreas: a strategy of superextended surgery combined with targeted therapy.扩大胰十二指肠切除术联合门静脉和下腔静脉切除重建并联合索拉非尼治疗胰腺肝样腺癌：一种扩大手术联合靶向治疗的策略
Hepatobiliary Surg Nutr. 2023 Aug 1;12(4):637-640. doi: 10.21037/hbsn-23-74. Epub 2023 Jul 14.
2
[Successful R0 Resection of Hilar Cholangiocarcinoma Invading the Inferior Vena Cava through Left Trisegmentectomy with Combined Resection of the Portal Vein and Inferior Vena Cava after Gemcitabine/Cisplatin Combination Chemotherapy-A Case Report].[吉西他滨/顺铂联合化疗后经左半肝三叶切除术联合门静脉及下腔静脉切除成功R0切除侵犯下腔静脉的肝门部胆管癌——病例报告]
Gan To Kagaku Ryoho. 2022 Apr;49(4):437-439.
3
Recurrence-free survival of a hepatocellular carcinoma patient with tumor thrombosis of the inferior vena cava after treatment with sorafenib and hepatic resection.索拉非尼联合肝切除术后下腔静脉肿瘤血栓形成的肝细胞癌患者的无复发生存期
Int Surg. 2015 May;100(5):908-14. doi: 10.9738/INTSURG-D-14-00133.1.
4
An Adrenal Hepatoid Adenocarcinoma with Left Renal Vein Thrombosis Extending into the Inferior Vena Cava.一例肾上腺肝样腺癌伴左肾静脉血栓形成并延伸至下腔静脉。
Urol J. 2019 Oct 21;16(5):511-514. doi: 10.22037/uj.v0i0.5250.
5
Robot Assisted Laparoscopy Combined with Thoracoscopy in the Treatment of Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombus.机器人辅助腹腔镜联合胸腔镜治疗肝癌合并下腔静脉癌栓。
Ann Surg Oncol. 2023 Sep;30(9):5447-5449. doi: 10.1245/s10434-023-13512-5. Epub 2023 Jun 7.
6
Resection of recurrent hepatocellular carcinoma with thrombi in the inferior vena cava, right atrium, and phrenic vein: a report of three cases.复发性肝细胞癌合并下腔静脉、右心房和膈静脉血栓切除术：三例报告。
World J Surg Oncol. 2020 Jun 22;18(1):138. doi: 10.1186/s12957-020-01914-8.
7
Relationship between encephalopathy and portal vein-vena cava shunt: value of computed tomography during arterial portography.脑病与门静脉-腔静脉分流术之间的关系：动脉性门静脉造影期间计算机断层扫描的价值
World J Gastroenterol. 2004 Jul 1;10(13):1939-42. doi: 10.3748/wjg.v10.i13.1939.
8
Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case according to modified RECIST criteria.索拉非尼联合放射治疗用于门静脉和肝静脉侵犯延伸至下腔静脉的晚期肝细胞癌：根据改良RECIST标准的完全缓解病例
J Liver Cancer. 2022 Mar;22(1):63-68. doi: 10.17998/jlc.2022.01.18. Epub 2022 Feb 14.
9
Safety and Efficacy of Inferior Vena Cava Reconstruction During Hepatic Resection.肝切除术中下腔静脉重建的安全性和有效性。
Scand J Surg. 2019 Sep;108(3):194-200. doi: 10.1177/1457496918798213. Epub 2018 Sep 24.
10
Capacitance of the rabbit portal vein and inferior vena cava.兔门静脉和下腔静脉的电容
J Physiol. 1986 Dec;381:417-25. doi: 10.1113/jphysiol.1986.sp016335.

引用本文的文献

1
A narrative review on rare types of pancreatic cancer: should they be treated as pancreatic ductal adenocarcinomas?关于罕见类型胰腺癌的叙述性综述：它们应被视为胰腺导管腺癌进行治疗吗？
Ther Adv Med Oncol. 2024 Jul 26;16:17588359241265213. doi: 10.1177/17588359241265213. eCollection 2024.
2
Case report and literature analysis: pancreatic hepatoid carcinoma with multiple lymph node metastases progressing to liver metastasis after pancreaticoduodenectomy.病例报告与文献分析：胰腺肝样腺癌伴多发淋巴结转移，胰十二指肠切除术后进展为肝转移
Front Oncol. 2024 Apr 26;14:1335647. doi: 10.3389/fonc.2024.1335647. eCollection 2024.

本文引用的文献

1
Alpha-fetoprotein producing pancreatic neuroendocrine tumour.产生甲胎蛋白的胰腺神经内分泌肿瘤
QJM. 2020 Aug 1;113(8):565-566. doi: 10.1093/qjmed/hcaa018.
2
Hepatoid Carcinoma of the Pancreas: A Case Report and Review of the Literature.胰腺肝样癌：一例报告并文献复习
Case Rep Pancreat Cancer. 2015 Nov 1;1(1):3-6. doi: 10.1089/crpc.2015.29001.nlw. eCollection 2015.
3
Immunotherapy and Prevention of Pancreatic Cancer.胰腺癌的免疫治疗与预防
Trends Cancer. 2018 Jun;4(6):418-428. doi: 10.1016/j.trecan.2018.04.001. Epub 2018 Apr 30.
4
Neoadjuvant modified-FOLFIRINOX followed by surgical resection of both the primary and metastatic tumors of a pancreatic hepatoid carcinoma with synchronous liver metastasis: A case report.新辅助改良FOLFIRINOX方案治疗后对同时发生肝转移的胰腺肝样腺癌的原发肿瘤和转移瘤进行手术切除：1例病例报告
Medicine (Baltimore). 2017 Oct;96(43):e8413. doi: 10.1097/MD.0000000000008413.
5
Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma.磷脂酰肌醇蛋白聚糖-3和细胞角蛋白19是与胰腺导管腺癌转移及预后不良相关的标志物。
Cancer Biomark. 2016;17(4):397-404. doi: 10.3233/CBM-160655.
6
Hepatoid carcinoma of the pancreas with lymphoid stroma: first description of the clinical, morphological, immunohistochemical, and molecular characteristics of an unusual pancreatic carcinoma.伴有淋巴样间质的胰腺肝样癌：一种罕见胰腺癌的临床、形态学、免疫组化及分子特征的首次描述
Virchows Arch. 2015 Aug;467(2):237-45. doi: 10.1007/s00428-015-1788-6. Epub 2015 May 20.
7
Successful treatment of a case with pancreatic neuroendocrine carcinoma with focal hepatoid differentiation: a case report and literature review.胰腺神经内分泌癌伴局灶性肝样分化1例的成功治疗：病例报告及文献复习
Int J Clin Exp Med. 2014 Oct 15;7(10):3588-94. eCollection 2014.
8
Huge pancreatic acinar cell carcinoma with high levels of AFP and fucosylated AFP (AFP-L3).伴有高水平甲胎蛋白（AFP）和岩藻糖基化甲胎蛋白（AFP-L3）的巨大胰腺腺泡细胞癌
Intern Med. 2012;51(11):1341-9. doi: 10.2169/internalmedicine.51.6536. Epub 2012 Jun 1.
9
A rare case of metastatic pancreatic hepatoid carcinoma treated with sorafenib.索拉非尼治疗转移性胰腺肝样癌的罕见病例。
J Gastrointest Cancer. 2012 Mar;43(1):97-102. doi: 10.1007/s12029-011-9264-2.
10
Hepatoid adenocarcinoma - review of the literature illustrated by a rare case originating in the peritoneal cavity.肝样腺癌——以一例起源于腹膜腔的罕见病例为例的文献综述
Onkologie. 2010;33(5):263-9. doi: 10.1159/000305717. Epub 2010 Apr 13.